Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 1998, p. 3296-3300, Vol. 42, No. 12
Département de biologie médicale,
Pavillon Marchand, Université Laval, Ste-Foy, Québec,
Canada G1K 7P4
Received 6 April 1998/Returned for modification 28 July
1998/Accepted 23 September 1998
The ampD and ampE genes of
Pseudomonas aeruginosa PAO1 were cloned and characterized.
These genes are transcribed in the same orientation and form an operon.
The deduced polypeptide of P. aeruginosa ampD exhibited
more than 60% similarity to the AmpD proteins of enterobacteria and
Haemophilus influenzae. The ampD product
transcomplemented Escherichia coli ampD mutants to
wild-type Most Pseudomonas
aeruginosa strains, like nearly all members of the family
Enterobacteriaceae, express an inducible chromosomally encoded AmpC In P. aeruginosa, the inducible expression of AmpC
The strains and plasmids used in this study are described in Table
1. E. coli DH5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
An ampD Gene in Pseudomonas
aeruginosa Encodes a Negative Regulator of AmpC
-Lactamase Expression
![]()
ABSTRACT
Top
Abstract
Text
References
-lactamase expression.
![]()
TEXT
Top
Abstract
Text
References
-lactamase (cephalosporinase) (27), which is
placed in class C of Ambler's classification (1)
and which is in Bush's group 1 (3). In enterobacteria,
the regulation of AmpC
-lactamase expression is intimately
linked to cell wall recycling and involves three genes;
ampR, which encodes a transcriptional regulator of the LysR
family; ampG, which encodes a transmembrane permease; and
ampD, which encodes a cytosolic
N-acetyl-anhydromuramyl-L-alanine amidase
hydrolyzing 1,6-anhydromuropeptides (9, 12, 15, 25). In the
absence of a
-lactam inducer, AmpR is repressed by the murein
precursor UDP-MurNAc-pentapeptide
(uridine- pyrophosphoryl-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) (13). Since
-lactams interfere with murein synthesis, their actions lead
to an increased periplasmic accumulation of degradation
products such as 1,6-anhydromuropeptides, which are the
signal molecules for
-lactamase induction (5, 11).
ampG transports these products from periplasm to
cytoplasm, where they are cleaved by AmpD, which acts as a
negative regulator of AmpC
-lactamase expression (5,
11, 15, 25). In ampD mutants, the
constitutive overproduction of AmpC
-lactamase is accompanied by an
ac- cumulation of aM-tripeptide (monosaccharide-tripeptide, 1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-di-aminopimelic acid) and aM-pentapeptide (monosaccharide-pentapeptide, 1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glu-tamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) in the cytoplasm
(5, 11). Jacobs et al. (13) suggested that the
aM-tripeptide could be the AmpR-activating ligand, since this
product can relieve in vitro the repressed state of AmpR, resulting in
the activation of
-lactamase expression. However, potential
interactions of the aM-pentapeptide with AmpR have not been
investigated. Another gene, ampE, which encodes a
transmembrane protein, forms an operon with ampD, but this
gene is not involved in
-lactamase expression (10, 19,
24).
-lactamase is also under the control of the transcriptional
regulator AmpR (21). To further elucidate the induction
process, the ampD and ampE genes of this organism
were cloned and characterized, and complementation analysis was
performed with Escherichia coli ampD mutants with the cloned
P. aeruginosa ampD and ampE genes. A part of this
work was presented before (16).
was used as
the host for construction and propagation of recombinant plasmids.
Bacterial cells were grown in tryptic soy broth or tryptic soy agar
(Difco Laboratories, Detroit, Mich.). When required, 50 µg of
kanamycin/ml, 30 µg of chloramphenicol/ml, and various
concentrations of cefotaxime, ampicillin, and cefoxitin were
added (Sigma-Aldrich Canada, Oakville, Ontario, Canada).
TABLE 1.
Characteristics of the bacterial strains and plasmids
used in this study
Recombinant DNA techniques were performed essentially by standard
procedures (26). To clone the ampD and
ampE genes of P. aeruginosa PAO1, two degenerated
oligonucleotide primers adapted to the P. aeruginosa codon
usage and derived from two conserved regions of the E. coli,
Citrobacter freundii, and Enterobacter cloacae AmpD amino acid sequences (10, 14, 19)
were synthesized on a 394 DNA/RNA synthesizer (PE Applied Biosystems,
Foster City, Calif.). The sequences of the primers were as follows:
AmpD1, 5'-CGCTGCCSCCSGGCGARTTCG-3'; and AmpD2,
5'-CGGGGCCSGGGTCGGTCTTGC-3'. A 400-bp DNA fragment was
amplified by PCR with the Taq DNA polymerase (Promega,
Madison, Wis.) and a P. aeruginosa PAO1 lysate, the latter of which was prepared by the freezing-and-boiling method (30). This DNA fragment was used as a probe to screen a
Zap Express genomic library of P. aeruginosa PAO1. Phage
screening and in vivo plasmid excision were performed according to the
instructions of the manufacturer (Stratagene, La Jolla, Calif.). A
single phage containing a 6.7-kb genomic insert was selected,
and plasmid pBK-CMV was excised out of the phage and named
pHUL4DE-PH. The ampD gene was located on a 2.6-kb
EcoRI fragment of pHULDE-PH, which was cloned into the
EcoRI site of pBGS19+ vector to generate
plasmid pHUL4DE-1. Both strands of this DNA fragment were
sequenced with the Deaza sequencing kit (Pharmacia Biotech, Baie
d'Urfé, Québec, Canada) on a Pharmacia LKB Macrophor or
the ABI Prism dye terminator cycle sequencing kit with AmpliTaq DNA
polymerase, FS (PE Applied Biosystems), on a 373 DNA sequencer (PE
Applied Biosystems). Sequence analysis, alignment, the homology study, G + C content calculation, and molecular mass prediction were done with the Genetics Computer Group software package version 9.0 (Madison, Wis.). The PSORT software was used to predict protein localization sites (22).
Sequence analysis of this DNA fragment revealed three complete open
reading frames (ORFs) (Fig. 1). The first
567-bp ORF is located 657 nucleotides downstream of the
EcoRI site and encodes a 188-amino-acid polypeptide (AmpD)
with a predicted molecular mass of 21 kDa. A potential Shine-Dalgarno
(SD) sequence (AGGAG) (8) and the consensus
10
(TAGAGT) and
35 (TCGTCA) regions of bacterial
promoters (20) were identified 5, 23, and 45 nucleotides upstream of the ampD ATG start codon, respectively.
Following ampD, a second ORF (AmpE) of 837 nucleotides,
which consists of 278 amino acids with a predicted molecular mass of 31 kDa, was found. The ampE ATG start codon overlaps the
ampD TGA termination codon and is preceded by a potential SD
sequence (AGGAG) located 5 nucleotides upstream. This strongly suggests
that these two genes form an operon, as described for
E. coli (10, 19). The G + C contents of
ampD and ampE were calculated to be 64 and 68%, respectively, which are typical for P. aeruginosa
(32). Finally, 92 nucleotides downstream of the
ampE TGA stop codon, a 282-bp ORF (ORF-1), which comprises
93 amino acids with a predicted molecular mass of 10 kDa (Fig. 1), was
identified. This ORF is transcribed in the same orientation as
ampDE and is preceded by a potential SD sequence (AGGTG) as
well as the
10 (CGATAT) and
35 (TTAACC) promoter-like sequences at 11, 25, and 52 nucleotides
upstream of its ATG start codon, respectively. The product of ORF-1,
like AmpD, possesses the features of a cytoplasmic protein
(22). Three other potential ORFs (ORF-a, ORF-b, and ORF-c)
from different reading frames, which are incomplete at the 5' end, were
also identified on each side of ampDE (Fig. 1). However,
these ORFs, like ORF-1, showed no significant homology to any sequence
in the GenBank database.
|
The predicted P. aeruginosa AmpD protein exhibited 65, 63, 62, and 62% similarity to the E. coli, C. freundii, E. cloacae, and putative Haemophilus influenzae AmpD proteins, respectively (7, 10, 14, 19). Amino acid sequence alignment of these AmpD proteins revealed many conserved motifs (Fig. 2). The conserved core region as well as the four strictly identical residues outside of this region, which relate the AmpD proteins of enterobacteria to the cell wall hydrolases of Bacillus spp. (12), were found in the P. aeruginosa AmpD protein. The deduced P. aeruginosa AmpE protein possesses the features of a cytoplasmic membrane protein (22) with five transmembrane-spanning domains (Fig. 1). It showed a low degree of similarity (33%) to its homolog in E. coli (10, 19) and seems to be less conserved than AmpD. Indeed, this difference with regard to AmpE is underlined by the fact that despite the identification of a putative ampD sequence in the genome sequence database of H. influenzae, no ampE sequence could be identified (7).
|
To determine the role of the P. aeruginosa ampD and
ampE gene products, complementation analyses were
performed with E. coli strains JRG582
[
(ampDE)2] and STC172 (ampD11E+)
(10, 18) with the cloned P. aeruginosa
ampD and ampE genes. The MICs of
-lactam antibiotics
for transformants were determined by the broth microdilution method as
described previously (31). Induction assays and
-lactamase activity measurements were performed as described
previously (31). Two plasmids were constructed to do a
complementation study. Plasmid pHUL4DE-2, which contains the
ampDE operon and the 105- and 209-nucleotide regions
located upstream and downstream of this operon, respectively,
was constructed as follows: a 1,714-bp DNA fragment was amplified by
PCR with the Pfu DNA polymerase (Stratagene) and the
oligonucleotide primers AmpD-14
(5'-GGGAATTCCTTTCCTCGAAGCATGTCG-3') and AmpD-15
(5'-GGGATAGAGTACGGTCTTC-3') (Fig. 1). This DNA fragment was
cloned into the SmaI site of pBGS19+ vector.
Plasmid pHUL4D, which contains the complete ampD gene and
the first 317 nucleotides encoding AmpE, was constructed by cloning a
984-bp DNA amplification product into the SmaI site of
pBGS19+ vector. This fragment was amplified as described
above with the oligonucleotide primers AmpD-14 and AmpE-4
(5'-CGCCGCCAGGCGTCGCG-3') (Fig. 1). The sequences of all
cloned PCR DNA fragments were confirmed by complete resequencing.
Since E. coli strains do not contain ampR
(24), the E. coli strains STC172 and JRG582
were first transformed with plasmid pEC1C carrying ampC and
ampR of E. cloacae (23). The data
in Table 2 show that STC172/pEC1C
exhibits a high basal
-lactamase activity and is
hyperinducible, while JRG582/pEC1C has a fully derepressed
phenotype, as shown previously (10). Both of these constructs were highly resistant to ampicillin and cefotaxime. The
ampD genes of both E. coli and
P. aeruginosa, as expressed from pNH5 and pHUL4D,
respectively, transcomplemented the E. coli ampD and ampDE mutants to low-level
-lactam
resistance and wild-type
-lactamase expression (low basal level and
inducibility) (Table 2). This shows that the cloned P. aeruginosa ampD gene expresses a functional AmpD protein in
E. coli cells. These data, as well as the high
homology observed among the AmpD proteins, strongly suggest that
P. aeruginosa AmpD acts as an
N-acetyl-anhydromuramyl-L-alanine amidase, which
leads to a decreased amount of anhydromuropeptide, the signal
molecule for
-lactamase expression (5, 9, 11, 12). The
induced/noninduced ratio of
-lactamase activity was more
than 7.5 times lower in cells producing the E. coli
AmpD than that in cells containing P. aeruginosa AmpD,
and this could be explained by the presence of a very strong promoter
behind E. coli ampD.
|
The MICs, as well as the basal and induced levels, of
-lactamase were almost the same for cells containing AmpD as
those for cells containing AmpD and AmpE. This strongly
suggests that similar to the E. coli protein,
P. aeruginosa AmpE has no effect on
-lactamase
expression (24). This protein, like its homolog in
E. coli (10, 19), has the features of an
integral inner membrane protein, but its role in the bacterial cell is
still unknown.
Expression of ORF-1 together with ampDE from plasmid
pHULDE-1 reduced by more than 1.7-fold the induced level of
-lactamase in both E. coli ampD and ampDE
mutants, compared to that in strains producing AmpD and AmpE. This
suggests that the product of this ORF, which has the features of a
cytoplasmic protein, may affect
-lactamase expression in the
presence of a
-lactam inducer, perhaps by interacting directly with
AmpD or by acting as a regulator of ampD expression, or
perhaps by a new unknown mechanism. Further experiments are needed to
explore the role of this ORF.
The high degree of homology among the various AmpD proteins shows that
AmpD of P. aeruginosa is in its evolution very close to
its homologs in enterobacteria, and they probably share a common mechanism of regulation of AmpC
-lactamase expression and murein metabolism. In our approach to characterizing the mechanism of regulation of AmpC
-lactamase production in P. aeruginosa, a putative ampG gene was also cloned and
characterized (17). This further strengthens the close
relationships between the P. aeruginosa and
enterobacterial AmpC
-lactamase induction mechanism and cell wall recycling.
In enterobacteria, three out of four phenotypes of altered
-lactamase expression have been associated with mutations in
ampD (2, 6, 10, 14, 19, 29). In clinical and
laboratory isolates of P. aeruginosa, three phenotypes
of altered
-lactamase expression have also been described (4,
27), and a study is in progress to characterize the
ampD gene in some of these isolates.
Nucleotide sequence accession number. The nucleotide sequence data for the ampD and ampE genes appear in the GenBank database under accession no. AF082575.
| |
ACKNOWLEDGMENTS |
|---|
We thank S. T. Cole, Institut Pasteur, Paris, France, for
E. coli JRG582 and STC172 and plasmids pEC1C and pNH5;
G. Vézina, Université Laval, for the
ZAP Express
genomic library of P. aeruginosa PAO1; L. Gagnon,
Université Laval, for assistance with computer analysis; and M. Goldner, Université Laval, for critically reading the manuscript.
This work was supported by the Canadian Cystic Fibrosis Foundation and, in part, by Canada's Networks of Centres of Excellence (CBDN).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Département de biologie médicale, Pavillon Marchand, Université Laval, Ste-Foy, Québec Canada G1K 7P4. Phone: (418) 656-2131, ext. 2669. Fax: (418) 656-7176. E-mail: ann.huletsky{at}rsvs.ulaval.ca.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ambler, R. P.
1980.
The structure of -lactamases.
Philos. Trans. R. Soc. London Ser. B.
289:321-331 |
| 2. |
Bennett, P. M., and I. Chopra.
1993.
Molecular basis of -lactamase induction in bacteria.
Antimicrob. Agents Chemother.
37:153-158 |
| 3. |
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 4. |
Campbell, J. I. A.,
O. Ciofu, and N. Høiby.
1997.
Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different -lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region.
Antimicrob. Agents Chemother.
41:1380-1384[Abstract].
|
| 5. |
Dietz, H.,
D. Pfeifle, and B. Wiedemann.
1997.
The signal molecule for -lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide.
Antimicrob. Agents Chemother.
41:2113-2120[Abstract].
|
| 6. | Ehrhardt, A. F., C. C. Sanders, J. R. Romero, and J. S. Leser. 1996. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob. Agents Chemother. 40:1953-1956[Abstract]. |
| 7. |
Fleischmann, R. D.,
M. D. Adams,
O. White,
R. A. Clayton,
E. F. Kirkness, et al.
1995.
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd.
Science
269:496-512 |
| 8. | Gold, L. 1988. Posttranscriptional regulatory mechanisms in Escherichia coli. Annu. Rev. Biochem. 57:199-233[Medline]. |
| 9. |
Höltje, J.-V.,
U. Kopp,
A. Ursinus, and B. Wiedemann.
1994.
The negative regulator of -lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase.
FEMS Microbiol. Lett.
122:159-164[Medline].
|
| 10. | Honoré, N., M. H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol. Microbiol. 3:1121-1130[Medline]. |
| 11. |
Jacobs, C.,
L. J. Huang,
E. Bartowsky,
S. Normark, and J. T. Park.
1994.
Bacterial cell wall recycling provides cytosolic muropeptides as effectors for -lactamase induction.
EMBO J.
13:4684-4694[Medline].
|
| 12. |
Jacobs, C.,
B. Joris,
M. Jamin,
K. Klarsov,
J. Van Beeumen,
D. Mengin-Lecreulx,
J. van Heijenoort,
J. T. Park,
S. Normark, and J.-M. Frère.
1995.
AmpD, essential for both -lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase.
Mol. Microbiol.
15:553-559[Medline].
|
| 13. |
Jacobs, C.,
J.-M. Frère, and S. Normark.
1997.
Cytosolic intermediates for cell wall biosynthesis and degradation control inducible -lactam resistance in gram-negative bacteria.
Cell
88:823-832[Medline].
|
| 14. |
Kopp, U.,
B. Wiedemann,
S. Lindquist, and S. Normark.
1993.
Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae.
Antimicrob. Agents Chemother.
37:224-228 |
| 15. |
Korfmann, G., and C. C. Sanders.
1989.
ampG is essential for high-level expression of AmpC -lactamase in Enterobacter cloacae.
Antimicrob. Agents Chemother.
33:1946-1951 |
| 16. | Langaee, T. Y., and A. Huletsky. 1996. Characterization of the ampD gene encoding a regulator of cephalosporinase expression in Pseudomonas aeruginosa PAO1, abstr. A-37, p. 139. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C. |
| 17. |
Langaee, T. Y., and A. Huletsky.
1997.
Identification of the ampG gene encoding a signal transducer for induction of the chromosomal AmpC -lactamase in Pseudomonas aeruginosa PAO1, abstr. A-3, p. 1.
In
Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
|
| 18. |
Langley, D., and J. R. Guest.
1977.
Biochemical genetics of the alpha-keto acid dehydrogenase complexes of Escherichia coli K12: isolation and biochemical properties of deletion mutants.
J. Gen. Microbiol.
99:263-276 |
| 19. |
Lindquist, S.,
M. Galleni,
F. Lindberg, and S. Normark.
1989.
Signalling proteins in enterobacterial AmpC -lactamase regulation.
Mol. Microbiol.
3:1091-1102[Medline].
|
| 20. |
Lisser, S., and H. Margalit.
1993.
Compilation of E. coli mRNA promoter sequences.
Nucleic Acids Res.
21:1507-1516 |
| 21. | Lodge, J., S. Busby, and L. Piddock. 1993. Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC promoter. FEMS Microbiol. Lett. 111:315-320[Medline]. |
| 22. | Nakai, K., and M. Kanehisha. 1991. Expert system for predicting protein localization sites in gram-negative bacteria. Proteins 11:95-110[Medline]. |
| 23. |
Nicolas, M. H.,
N. Honore,
V. Jarlier,
A. Philippon, and S. T. Cole.
1987.
Molecular genetic analysis of cephalosporinase production and its role in -lactam resistance in clinical isolates of Enterobacter cloacae.
Antimicrob. Agents Chemother.
31:295-299 |
| 24. |
Normark, S.,
E. Bartowsky,
J. Erickson,
C. Jacobs,
F. Lindberg,
S. Lindquist,
K. Weston-Hafer, and M. Wikström.
1994.
Mechanisms of chromosomal -lactamase induction in Gram-negative bacteria, p. 485-503.
In
J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B.V., Amsterdam, The Netherlands.
|
| 25. |
Normark, S.
1995.
-Lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling.
Microb. Drug Resist.
1:111-114.
[Medline] |
| 26. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 1.21-1.101. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 27. |
Sanders, C. C., and W. E. Sanders, Jr.
1992.
-Lactam resistance in gram-negative bacteria: global trends and clinical impact.
Clin. Infect. Dis.
15:825-839.
|
| 28. | Spratt, B. G., P. J. Hedge, S. Teheesen, A. Edelman, and J. K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene 41:337-342[Medline]. |
| 29. | Stapleton, P., K. Shannon, and I. Phillips. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob. Agents Chemother. 39:2494-2498[Abstract]. |
| 30. |
Starnbach, M. N.,
S. Falkow, and L. S. Tompkins.
1989.
Species-specific detection of Legionella pneumophila in water by DNA amplification and hybridization.
J. Clin. Microbiol.
27:1257-1261 |
| 31. | Trépanier, S., A. Prince, and A. Huletsky. 1997. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob. Agents Chemother. 41:2399-2405[Abstract]. |
| 32. | West, S. E. H., and B. H. Iglewski. 1988. Codon usage in Pseudomonas aeruginosa. Nucleic Acids Res. 6:9323-9335. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»